Site içinde arama yapın

bir ses eklendi Health

2025-02-18 12:09:01

Global Adalimumab Biosimilar Market: Innovations and Opportunities

Adalimumab, originally marketed under the brand name Humira, is one of the most widely prescribed biologic drugs for the treatment of autoimmune diseases like rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. With Humira approaching its patent expiry in recent years, the Adalimumab biosimilars market has emerged as a significant opportunity for both pharmaceutical...

0 Yorumlar 0 hisse senetleri 3K Views 0 önizleme